P090: NGS assay for simultaneous screening of DNA and RNA provides a comprehensive solution guiding clinical management of ALL patients

Documenti analoghi

• Identification and Characterization of Germline Mutations in Indian Women with Cancer: A Tertiary Center Next-Generation Sequencing Study
  di: Surender Dhanda, et al.
• An unusual case of Waldenstrom Macroglobulinemia with Mott cell differentiation in bone marrow – orchard of flower appearance
  di: Nupur Das, et al.
  Pubblicazione: (2025-01-01)
• NGS-based MRD monitoring in mature B-cell and plasma cell malignancies
  di: Roisin McAvera, et al.
  Pubblicazione: (2026-05-01)
• Prognostic impact of early NGS MRD dynamics and cytomolecular risk in newly diagnosed B-cell ALL
  di: Nicholas J. Short, et al.
  Pubblicazione: (2025-10-01)
• Hematrack: High sensitivity measurable residual disease (MRD) monitoring in acute lymphoblastic leukemia with NGS
  di: Vineeth Surendranath, et al.
  Pubblicazione: (2024-01-01)